After Hours Gainer
ACRV Acrivon Therapeutics9.50-0.32-3.3%
After Hours:10.76+1.26 (+13.3%)
Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event
Globe NewswireWed, 24-Apr 4:01 PM
After Hours:10.83+1.33 (+14.0%)